Table 4.

Outcomes by Admission Quarter for Patients With Ischemic Stroke Admitted to GWTG Participating Nonteaching Hospitals

Variable	Level	Overall	Jul–Sep	Oct–Dec	Jan–Mar	Apr–Jun	P Value
Nonteaching hospitals, n		403 419	100 440	102 093	100 484	100 402
In hospital mortality, %	Yes	4.16	3.76	4.30	4.48	4.10	<0.0001
Home discharge, %	Yes	49.88	50.96	49.33	48.80	50.43	<0.0001
Independent ambulatory status at discharge, %	Yes	49.39	50.56	48.95	48.18	49.83	<0.0001
LOS >4 d, %	Yes	37.20	36.28	37.50	38.44	36.60	<0.0001
Door‐to‐CT time, min	Median (Q1–Q3)	46 (23–86)	45 (23–85)	44 (22–84)	47 (24–89)	46 (24–86)	<0.0001
Door‐to‐CT <25 min, %	Yes	26.80	27.11	27.95	25.81	26.29	<0.0001
Door‐to‐needle time	Median (Q1–Q3)	75 (56–98)	74 (56–96)	73 (56–96)	77 (58–100)	75 (56–98)	<0.0001
Door‐to‐needle time <60 min, %	Yes	29.83	31.15	31.39	26.84	29.80	<0.0001
Arrive by 2 h and treated by 3 h, %	Yes	77.50	78.12	78.96	75.39	77.49	<0.0001
Early antithrombotic, %	Yes	96.80	96.91	96.94	96.43	96.93	<0.0001
VTE prophylaxis, %	Yes	97.04	97.14	97.18	96.90	96.91	0.0055
Antithrombotics, %	Yes	98.42	98.46	98.58	98.21	98.44	<0.0001
Anticoagulation for atrial fibrillation/flutter, %	Yes	93.87	94.05	94.00	93.74	93.68	0.5082
Smoking cessation, %	Yes	96.91	96.99	97.02	96.89	96.73	0.4524
LDL 100 or ND—statin, %	Yes	94.25	94.56	94.48	93.76	94.13	<0.0001
Defect‐free measure, %	Yes	89.77	90.15	89.90	89.24	89.80	<0.0001
Symptomatic intracranial hemorrhage <36 h	Yes	4.53	4.41	4.75	4.37	4.59	0.6937

CT indicates computerized tomography; GWTG, Get With The Guidelines; LDL, low‐density lipoprotein; LOS, length of stay; ND, not determined; Q1–Q3, 25th to 75th percentiles; VTE, venous thromboembolism.